Harvard Perspectives on Prostate Disease

Advances and breakthroughs in prostate disease

Reviewed by Per-Anders Abrahamsson, M.D., Ph.D.

Advances in the understanding and treatment of prostate disease are constantly being reported at scientific meetings and in peer-reviewed publications. What follows are some of the most interesting recent findings, placed in context by Dr. Abrahamsson, a member of Perspectives' advisory and editorial board and Secretary General of the European Association of Urology, the leading professional organization overseas.

Experimental prostate cancer "vaccine" prolongs survival

Ever since the FDA asked in May 2007 for more proof that the drug sipuleucel-T (Provenge) really works, prostate cancer patients and their physicians have eagerly awaited additional data on the investigational "vaccine." The wait came to an end in April, when researchers presented phase III findings from the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) study at the American Urological Association's annual meeting.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »